← SynDRA
SERDEMETAN
SynDRA canonical compound SYN0033790 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Primary target(s) | MDM2 |
| Mechanism of action | MDM inhibitor |
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- JNJ-26854165
- N1-(2-(1H-Indol-3-yl)ethyl)-N4-(pyridin-4-yl)benzene-1,4-diamine
- JNJ 26854165 (Serdemetan)
- UNII-ID6YB4W3V8
- ID6YB4W3V8
- C21H20N4
- n-(2-(1h-indol-3-yl)ethyl)-n'-(4-pyridinyl)-1,4-benzenediamine
- N-[2-(1H-INDOL-3-YL)ETHYL]-N'-(4-PYRIDINYL)-1,4-BENZENEDIAMINE
- Serdemetan [INN]
- MLS006011022
- SCHEMBL3012498
- CHEMBL2137530
- CTK8C1936
- EX-A267
- DTXSID30236830
- MolPort-009-679-468
- HMS3654A16
- BCP02124
- AOB87702
- QC-534
- ANW-67474
- JNJ 26854165
- JNJ26854165
- 1-N-[2-(1H-indol-3-yl)ethyl]-4-N-pyridin-4-ylbenzene-1,4-diamine
- N-(2-(1H-Indol-3-yl)ethyl)-n'-(pyridin-4-yl)benzene-1,4-diamine
- SERDEMETAN [WHO-DD]
- 1,4-Benzenediamine, N-[2-(1H-indol-3-yl)ethyl]-N'-4-pyridinyl-
- MFCD16620518
- s1172
- ZINC15965745
- AKOS016006774
- CCG-264846
- CS-0166
- DB12027
- NCGC00263171-01
- NCGC00263171-08
- AC-33109
- AS-56263
Look up SERDEMETAN in the interactive SynDRA portal →